Your browser doesn't support javascript.
loading
Can we stop one heart from breaking: triumphs and challenges in cardiac reprogramming.
Spurlock, Brian; Liu, Jiandong; Qian, Li.
Afiliación
  • Spurlock B; McAllister Heart Institute, Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC 27599, USA. Electronic address: https://twitter.com/@brineshrimp2.
  • Liu J; McAllister Heart Institute, Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC 27599, USA.
  • Qian L; McAllister Heart Institute, Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC 27599, USA. Electronic address: li_qian@med.unc.edu.
Curr Opin Genet Dev ; 83: 102116, 2023 Dec.
Article en En | MEDLINE | ID: mdl-37797568
Ischemic cardiac injury causes irreversible muscle loss and scarring, but recent years have seen dramatic advances in cardiac reprogramming, the field focused on regenerating cardiac muscle. With SARS-CoV2 increasing the age-adjusted cardiovascular disease mortality rate, it is worth evaluating the state of this field. Here, we summarize novel innovations in reprogramming strategies, insights into their mechanisms, and technologies for factor delivery. We also propose a broad model of reprogramming to suggest directions for future research. Poet Emily Dickinson wrote, "If I can stop one heart from breaking, I shall not live in vain." Today, researchers studying cardiac reprogramming view this line as a call to action to translate this revolutionary approach into life-saving treatments for patients with cardiovascular diseases.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Miocitos Cardíacos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Curr Opin Genet Dev Asunto de la revista: GENETICA Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Miocitos Cardíacos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Curr Opin Genet Dev Asunto de la revista: GENETICA Año: 2023 Tipo del documento: Article
...